Shots: The P-III Checkmate-451 involves assessing Opdivo (nivolumab, 1mg/kg) + Yervoy (ipilimumab,3 mg/kg) vs PBO as a maintenance therapy in patients with extensive-stage small cell lung cancer (SCLC) The study […]readmore
Tags : Extensive-Stage SCLC